Brief: Arix Bioscience Says Amplyx Pharmaceuticals Closed A $53.0 Mln Series C Extension
20/05/2020 07:45
May 20 (Reuters) - Arix Bioscience PLC ARIX.L :
* AMPLYX PHARMACEUTICALS CLOSED A $53.0 MILLION SERIES C
EXTENSION
Source text for Eikon: ID:nPRrK027Ca
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co